Category Archives: Myocardial Infarction

Zhang L, Hailati J, Ma X, Liu J, Liu Z, Yang Y, et al. Analysis of risk factors for different subtypes of acute coronary syndrome Continue reading →

Dublin, June 20, 2024 (GLOBE NEWSWIRE) -- The "Global Myocardial Infarction Market Report by Drug Class, Distribution Channels, Regions and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's offering. The myocardial infarction market is set to grow significantly to reach US$ 3.43 billion by 2032, driven by an upsurge in heart-related diseases and coasted by progressive treatment solutions. An influx of advancements is enhancing patient outcomes and inspiring a healthier global populace. Continue reading →

Animal models have shown that cardiomyocytes can indeed regenerate. However, animal studies are not always directly transferable to a human setting. Continue reading →

Giudicessi JR, Kullo IJ, Ackerman MJ. Precision cardiovascular medicine: state of genetic testing. Mayo Clin Proc Continue reading →

A groundbreaking study by Massachusetts General Hospital has revealed potential strategies to reverse heart scarring post-myocardial infarction by comparing scar formation in zebrafish and mice. Continue reading →

A heart attack, medically known as a myocardial infarction, is a potentially life-threatening condition that occurs when blood flow to the heart is blocked, usually due to a build-up of plaque in the coronary arteries. This blockage prevents oxygen and nutrients from reaching the heart muscle, causing damage or death to the tissues. Why Does a Heart Attack Occur Continue reading →

Photo Credit: Stanislav Tarasov The following is a summary of Impact of time to revascularization on outcomes in patients after out-of-hospital cardiac arrest with STEMI, published in the May 2024 issue of Emergency Medicine by Nakajima, et al. Following out-of-hospital cardiac arrest (OHCA) with ST-segment elevation on electrocardiography, international guidelines recommended emergency coronary angiography. However, the impact of time to revascularization on outcomes in these patients remained unclear Continue reading →

Claudio Gil Arajo, MD, PhD (CLINIMEX, Rio de Janeiro, Brazil), had some good news for his 63-year-old patient who, just 3 weeks prior, successfully underwent PCI for STEMI. Sex, with his wife of many years, was back on the table Continue reading →

The prevalence and mortality of cardiovascular disease (CVD) continue to rise, and is one of the diseases threatening the health of Chinese people for a long time, of which the number of hospitalizations for acute ST-segment elevation myocardial infarction (STEMI) accounts for 86.8% of acute myocardial infarction (AMI), characterized by rapid onset, rapid progression, many complications, high mortality, and poor prognosis, and patients suffering from STEMI are more likely to develop major adverse cardiovascular events such as heart failure,high thrombus burden causing reinfarction and coronary microcirculation disturbance16,17, cardiogenic shock, stroke, and cardiac arrest than patients with other myocardial infarction types18,19. Although the establishment of chest pain centers and the workflow have continuously improved in various regions, the main means of treating the disease, percutaneous coronary intervention (PCI) treatment techniques, continue to mature. Continue reading →

Heart Attack Diagnostics Market Definition: The Heart Attack Diagnostics Market size was valued at USD 28 USD billion in 2023 and is projected to reach USD 12 USD billion by 2032, exhibiting a CAGR of 21.2 % during the forecast period. Heart Attack Diagnostics are procedures and tests applied to confirm acute myocardial infarction or heart attack. Continue reading →